HEALING & RECOVERY

TB-500

Synthetic thymosin beta-4 fragment. Investigated in actin-binding and cytoskeletal repair literature.

10 mgRUO · RESEARCH USE ONLY$103.99

Bundle & save

1

Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility

Free shipping

on orders over $150

Damage protection

replacement guarantee

Secure checkout

256-bit SSL

Certificate of Analysis

Third-party tested · ISO/IEC 17025 accredited

LATESTISO 170257+ TESTING

99.1%

purity

✓ Passed full QC panel

Variant
TB-500 · 10 mg
Lot #
AML-2026-0510
Labeled
10 mg
Tested
2026-04-18

Full QC panel

Purity (HPLC)
99.1%
Net Peptide Content
Pass
Identity (HPLC-MS)
Confirmed
Heavy Metals (ICP-MS)
Not detected
Sterility
No growth
Endotoxin (LAL)
Within limits
VIEW COA →

Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.

Compound Information

Chemical and structural properties

Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.

Molecular profile

Structure

CAS Number
77591-33-4
Molecular Formula
C212H350N56O78S
Molecular Weight
4963 g/mol
Sequence
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile (TB-4 active site)
Type
Research peptide

Biological targets

Interactions

Primary target
G-actin (actin-sequestering)
Pathway
Actin polymerization; cell migration; VEGF / angiogenesis
Mechanism
Thymosin β4 active-region peptide; binds G-actin and promotes cell migration
Research area
Tissue repair, cardiac and dermal wound research

Physical properties

Handling & Storage

Appearance
White to off-white lyophilized powder
Solubility
Soluble in sterile or bacteriostatic water; reconstitute prior to use
Storage
2-8 deg C, protect from light
Country of origin
USA

Sources & References

Peer-reviewed research

Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.

  • EXPERT OPINION ON BIOLOGICAL THERAPY

    Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

    2012 · PMID 22074294

    Goldstein AL et al.

    View Source ↗
  • ANNALS OF THE NEW YORK ACADEMY OF SCIENCES

    beta-Thymosins

    2007 · PMID 17468232

    Hannappel E

    View Source ↗
  • INTERNATIONAL IMMUNOPHARMACOLOGY

    Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies

    2023 · PMID 36709593

    Bock-Marquette I et al.

    View Source ↗
  • EXPERT OPINION ON BIOLOGICAL THERAPY

    Thymosin beta 4 and the eye: the journey from bench to bedside

    2018 · PMID 30063853

    Sosne G

    View Source ↗
  • CURRENT MEDICINAL CHEMISTRY

    Thymosin β4: A Multi-Faceted Tissue Repair Stimulating Protein in Heart Injury

    2020 · PMID 31333080

    Bjørklund G et al.

    View Source ↗

⚠ Important research notice

PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

All the research peptides you need, with the peace of mind at your fingertips.

Research updates from Aminologix

Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.